Fortuna Genomics empowers parents to optimize their child's potential through non-invasive genetic screening, enabling informed decisions for a brighter future. Learn more.
Fortuna builds genetic forecasting and screening technology to non-invasively assess embryo traits, enabling parents to optimize their children's innate qualities without the need for gene editing. Rather than attempting to influence these traits through nurture after birth, we provide a direct approach to managing the nature component of human development through genetic screening.
The target audience includes couples planning a pregnancy, and medical professionals in the fields of reproduction and infertility.